| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -7.96M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MBRX returned -95.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -82.1% |
| 1 year | -95.8% |
| 5 years | -99.9% |
| 10 years | -100.0% |
| All-time high | $15,705.00 (Jul 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MBRX would be worth today ›No. Moleculin Biotech, Inc. has not paid a dividend in the past 12 months.
Moleculin Biotech, Inc. stock trades on NASDAQ under the ticker symbol MBRX.
Moleculin Biotech, Inc. is part of the Healthcare sector.
Moleculin Biotech, Inc. has a market cap of 11.55M USD, based on the latest quote.
